IDX vs. XBI
IDX (VanEck Vectors Indonesia Index ETF) and XBI (SPDR S&P Biotech ETF) are both exchange-traded funds - IDX is a Asia Pacific Equities fund tracking the MVIS Indonesia Index, while XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, IDX returned -3.79%/yr vs 11.14%/yr for XBI. At a 0.33 correlation, their price movements are largely independent. IDX charges 0.57%/yr vs 0.35%/yr for XBI.
Performance
IDX vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDX achieves a -34.83% return, which is significantly lower than XBI's 20.70% return. Over the past 10 years, IDX has underperformed XBI with an annualized return of -3.79%, while XBI has yielded a comparatively higher 11.14% annualized return.
IDX
- 1D
- -0.55%
- 1M
- -2.54%
- YTD
- -34.83%
- 6M
- -35.84%
- 1Y
- -21.80%
- 3Y*
- -12.82%
- 5Y*
- -7.49%
- 10Y*
- -3.79%
XBI
- 1D
- 0.80%
- 1M
- 11.78%
- YTD
- 20.70%
- 6M
- 17.84%
- 1Y
- 79.53%
- 3Y*
- 20.24%
- 5Y*
- 1.51%
- 10Y*
- 11.14%
IDX vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IDX VanEck Vectors Indonesia Index ETF | -34.83% | 13.83% | -9.75% | 1.98% | -9.40% | -2.59% | -7.45% | 6.26% | -10.46% | 19.24% |
XBI SPDR S&P Biotech ETF | 20.70% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Correlation
The correlation between IDX and XBI is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jan 20, 2009 | 0.33 |
The correlation between IDX and XBI shifts across timeframes, from 0.18 (1 year) to 0.33 (all time), reflecting how their relationship changes across market environments.
IDX vs. XBI - Sectors Allocation Comparison
Sectors
IDX
XBI
Financial Services
Basic Materials
Consumer Defensive
-
Communication Services
-
Energy
-
Consumer Cyclical
-
Utilities
-
Technology
-
Healthcare
Real Estate
-
Industrials
-
Financial Services
IDX
XBI
Basic Materials
IDX
XBI
Consumer Defensive
IDX
XBI
-
Communication Services
IDX
XBI
-
Energy
IDX
XBI
-
Consumer Cyclical
IDX
XBI
-
Utilities
IDX
XBI
-
Technology
IDX
XBI
-
Healthcare
IDX
XBI
Real Estate
IDX
XBI
-
Industrials
IDX
XBI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDX vs. XBI — Risk / Return Rank
IDX
XBI
IDX vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Indonesia Index ETF (IDX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDX | XBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.82 | ||
| Sortino ratioReturn per unit of downside risk | -4.87 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.47 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 8.22 | -8.72 |
| Martin ratioReturn relative to average drawdown | -1.41 | 24.30 | -25.71 |
Loading charts...
Drawdowns
IDX vs. XBI - Drawdown Comparison
The maximum IDX drawdown since its inception was -63.14%, roughly equal to the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for IDX and XBI.
Loading charts...
Drawdown Indicators
| IDX | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.14% | -63.89% | +0.75% |
Max Drawdown (1Y)Largest decline over 1 year | -44.52% | -9.72% | -34.80% |
Max Drawdown (3Y)Largest decline over 3 years | -46.73% | -32.99% | -13.74% |
Max Drawdown (5Y)Largest decline over 5 years | -51.25% | -54.71% | +3.46% |
Max Drawdown (10Y)Largest decline over 10 years | -59.11% | -63.89% | +4.78% |
Current DrawdownCurrent decline from peak | -55.80% | -14.94% | -40.86% |
Average DrawdownAverage peak-to-trough decline | -24.92% | -20.93% | -3.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.47% | 3.28% | +12.19% |
Volatility
IDX vs. XBI - Volatility Comparison
VanEck Vectors Indonesia Index ETF (IDX) has a higher volatility of 13.48% compared to SPDR S&P Biotech ETF (XBI) at 9.96%. This indicates that IDX's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDX | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.48% | 9.96% | +3.52% |
Volatility (6M)Calculated over the trailing 6-month period | 24.92% | 21.31% | +3.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.38% | 26.47% | +0.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.01% | 32.30% | -11.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.47% | 32.01% | -7.54% |
IDX vs. XBI - Expense Ratio Comparison
IDX has a 0.57% expense ratio, which is higher than XBI's 0.35% expense ratio.
Dividends
IDX vs. XBI - Dividend Comparison
IDX's dividend yield for the trailing twelve months is around 3.20%, more than XBI's 0.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDX VanEck Vectors Indonesia Index ETF | 3.20% | 2.08% | 4.01% | 3.62% | 3.64% | 1.08% | 1.66% | 2.21% | 2.19% | 1.85% | 1.16% | 2.43% |
XBI SPDR S&P Biotech ETF | 0.39% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
IDX and XBI have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDX has higher volatility (13.48%) compared to XBI (9.96%). In terms of maximum drawdown, IDX dropped -63.14% vs XBI's -63.89%.
On 10-year performance, XBI leads with 11.14% vs -3.79% for IDX. On fees, XBI is cheaper at 0.35% per year. On volatility, XBI has been the lower-risk option at 9.96%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XBI has performed better with a 11.14% return vs -3.79%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XBI is cheaper with a 0.35% expense ratio, compared with 0.57% for IDX.
IDX has the higher dividend yield at 3.20%, compared with 0.39% for XBI.
IDX is categorized as Asia Pacific Equities, while XBI is Health & Biotech Equities. IDX tracks MVIS Indonesia Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: VanEck and State Street. Their fees differ too: 0.57% for IDX and 0.35% for XBI.
XBI currently has the higher Sharpe Ratio (3.02 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDX and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer